India Battles “Specious” Quality Allegations, Demurs on PIC/S
This article was originally published in The Gold Sheet
Executive Summary
India’s new Department of Pharmaceuticals Secretary Aradhana Johri said India will challenge the “specious issue” of quality that she says is raised in other countries to simply exclude the Indian industry. Meanwhile, the department continues to resist the entreaties of India’s domestic pharmaceutical manufacturers to seek membership in PIC/S, which would require strengthening its inspectorate in ways that would pressure them to meet international standards.